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Key questions
What is already known about this subject?
 ► Although the biology of aortic aneurysm and ath-
erosclerosis remains incompletely understood, both 
diseases share common risk factors and patho-
logical features. Inflammation and calcification 
of the aneurysm wall play a key role in initiation, 
progression and destabilisation in abdominal aortic 
aneurysm (AAA). Retrospective studies have been 
undertaken to assess inflammation and calcification 
in aneurysm subjects; however, prospective stud-
ies using state- of- the- art imaging protocols, and 
comparison with matched atherosclerotic controls 
is lacking.
What does this study add?
 ► This is the first study to measure both inflammation 
and calcification in patients with aneurysm and to 
compare it with age- and sex matched controls with 
atherosclerosis. The study adds several important 
mechanistic insights into the pathobiology of AAA. 
We observed that both aortic inflammation and 
calcification are greater in patients with aortic an-
eurysm than those with atherosclerosis alone, that 
aortic inflammation typically extends beyond the 
aneurysmal sac to involve the entirety of the aorta 
and that greater thrombus burden is associated with 
less inflammation.
How might this impact on clinical practice?
 ► We have demonstrated heightened inflammation 
extending beyond the aneurysmal segment in those 
with small to medium sized aneurysms. Prospective 
studies are now needed to evaluate the (1) the prog-
nostic value of measuring aortic inflammation and 
calcification to improve clinical decision- making in 
patients with asymptomatic AAA and (2) whether 
anti- inflammatory agents may reduce aneurysm 
formation and expansion.
AbstrAct
Objective Using combined positron emission 
tomography and CT (PET- CT), we measured aortic 
inflammation and calcification in patients with 
abdominal aortic aneurysms (AAA), and compared them 
with matched controls with atherosclerosis.
Methods We prospectively recruited 63 patients (mean 
age 76.1±6.8 years) with asymptomatic aneurysm 
disease (mean size 4.33±0.73 cm) and 19 age- and- sex- 
matched patients with confirmed atherosclerosis but no 
aneurysm. Inflammation and calcification were assessed 
using combined 18F- FDG PET- CT and quantified using 
tissue- to- background ratios (TBRs) and Agatston scores.
Results In patients with AAA, 18F- FDG uptake was 
higher within the aneurysm than in other regions of the 
aorta (mean TBR
max2.23±0.46 vs 2.12±0.46, p=0.02). 
Compared with atherosclerotic control subjects, both 
aneurysmal and non- aneurysmal aortae showed 
higher 18F- FDG accumulation (total aorta mean 
TBR
max2.16±0.51 vs 1.70±0.22, p=0.001; AAA mean 
TBRmax2.23±0.45 vs 1.68±0.21, p<0.0001). Aneurysms 
containing intraluminal thrombus demonstrated lower 
18F- FDG uptake within their walls than those without 
(mean TBR
max2.14±0.43 vs 2.43±0.45, p=0.018), with 
thrombus itself showing low tracer uptake (mean TBRmax 
thrombus 1.30±0.48 vs aneurysm wall 2.23±0.46, 
p<0.0001). Calcification in the aneurysmal segment 
was higher than both non- aneurysmal segments in 
patients with aneurysm (Agatston 4918 (2901–8008) 
vs 1017 (139–2226), p<0.0001) and equivalent regions 
in control patients (442 (304-920) vs 166 (80-374) 
Agatston units per cm, p=0.0042).
Conclusions The entire aorta is more inflamed 
in patients with aneurysm than in those with 
atherosclerosis, perhaps suggesting a generalised 
inflammatory aortopathy in patients with aneurysm. 
Calcification was prominent within the aneurysmal 
sac, with the remainder of the aorta being relatively 
spared. The presence of intraluminal thrombus, itself 
metabolically relatively inert, was associated with lower 
levels of inflammation in the adjacent aneurysmal wall.
Open Heart
2 Joshi NV, et al. Open Heart 2020;7:e001141. doi:10.1136/openhrt-2019-001141
IntROduCtIOn
Abdominal aortic aneurysm (AAA) is a matrix- 
degenerative vascular disorder resulting in aortic dilata-
tion (diameter >3 cm), with a prevalence of around 5% 
in adults aged 65–74 years. Patients tend to be asympto-
matic until rupture, which is often fatal.1
National ultrasound screening programmes for high- 
risk patients have significantly reduced deaths from 
rupture by identifying asymptomatic subjects with large 
aneurysms for elective surgical or endovascular repair. 
Once under surveillance, aneurysm diameter is moni-
tored by serial ultrasound, the frequency of which is 
determined by baseline aneurysm size.2 Repair is recom-
mended when the diameter exceeds 5.5 cm or where 
expansion is rapid. Importantly, smaller aneurysms (3.0–
5.5 cm) still account for a fifth of all ruptures, and some 
aneurysms can greatly exceed 5.5 cm without rupture, 
suggesting aneurysm size is not the only determinant of 
rupture.2 3 To improve risk stratification in patients with 
AAA, a better understanding of the pathobiology of the 
disease is needed.2
Imaging techniques can measure arterial inflamma-
tion and calcification in atherosclerosis and have poten-
tial for use in aneurysm disease.4–7 18- Fluorine- labelled 
2- deoxy-2- fluoro- D- glucose (18F- FDG) positron emission 
tomography–CT (PET- CT) is commonly used for risk 
stratification in cancer. This technique has been adapted 
to measure vascular metabolic activity and provides a 
reproducible, non- invasive measure of arterial inflamma-
tion, reflecting glucose uptake by macrophages and other 
plaque cells.8 9
Histologically, aneurysms are associated with inflamma-
tory infiltration, smooth muscle cell apoptosis and matrix 
degradation.10 These changes lead to weakening of the 
aortic wall, allowing expansion and rupture to occur. 
Although aneurysms are most common in the abdominal 
aorta, it has been suggested that the entire arterial system 
is abnormal in susceptible subjects, with dilatation of the 
carotid arteries being frequent in these patients.11In-
deed, the incidence of popliteal aneurysms in patients 
with AAA is in the range of 10%–20%.12
Atherosclerosis and aneurysm disease frequently 
co- exist and share some underlying risk factors and 
pathologies, including calcification and inflammation, 
but the magnitude and regional distribution of these is 
not known. In addition, it is not clear what role thrombus 
plays, when present, within an aneurysm. Conflicting 
reports suggest both protective and deleterious effects.13 14
It has been suggested that both inflammation and calci-
fication of the aneurysm wall are risk factors for aneu-
rysm expansion and destabilisation.4 15 Although some 
retrospective series have been published, what have been 
lacking are simultaneous, non- invasive measurements of 
inflammation and calcification in aneurysm subjects, 
using state- of- the- art imaging protocols, and compar-
ison with matched atherosclerotic controls without 
aneurysms.
To investigate these unanswered questions, this study 
aimed to determine the extent of inflammation and 
calcification in AAA and atherosclerosis using non- 
invasive imaging markers. We hypothesised that both 
aortic inflammation and calcification would be greater 
in aneurysm subjects than in matched controls with 
atherosclerosis, given that atherosclerosis is a disease 
largely confined to the intima, whereas AAA is a trans-
mural disease. We also hypothesised that inflammation in 
aneurysms would not be restricted to the dilated region 
of aorta, but would instead demonstrate a global pattern 
throughout the entire aorta, and that thrombus would 
be associated with low levels of aneurysm inflammation.
MetHOds
subjects
Patients were recruited from Addenbrooke’s Hospital, 
Cambridge and the Royal Infirmary of Edinburgh into 
two cohorts: (1) patients with asymptomatic AAA, and 
(2) age- and- sex- matched control patients with athero-
sclerosis but no aortic aneurysm disease (aneurysm was 
excluded using the non- contrast CT- derived aortic diam-
eter). All control subjects were recruited in Cambridge, 
with patients with aneurysm recruited at both sites. The 
inclusion criteria for the study cohort were age >50 years 
and presence of an aneurysm between 3.0 and 5.5 cm 
on ultrasound. The inclusion criteria for the control 
cohort were clinically stable (>6 months) cardiovas-
cular disease (defined as previous myocardial infarction, 
stroke or peripheral vascular disease). Exclusion criteria 
for both cohorts were type 1 or type 2 diabetes with a 
fasting glucose of >11 mmol/L, renal impairment (serum 
creatinine >250 µmol/L), contrast allergy or inability to 
provide informed consent.
Pet and Ct imaging
All patients underwent 18F- FDG PET- CT imaging of the 
entire aorta. In addition, patients in the aneurysm group 
underwent contrast- enhanced CT imaging of the aorta. 
We used validated, reproducible imaging protocols.7 16–18
Patient preparation
Patients fasted for 6 hours prior to PET imaging.
Image acquisition and reconstruction
In Cambridge, a GE Discovery 690 PET- CT scanner was 
used. In Edinburgh, an equivalent Siemens machine 
was used (Biograph mCT, Siemens Medical Systems, 
Erlangen, Germany). A target dose of 240 MBq 18F- FDG 
was injected intravenously, after which patients rested 
in a quiet environment for 90 min before being trans-
ferred to the scanner. A non- contrast- enhanced atten-
uation correction CT scan (40 mAs per rotation (Care-
Dose), 100 kV) was then performed followed by PET scan 
covering three bed positions from the arch of aorta to 
the aortic bifurcation over 30 min (10 min per bed posi-
tion). Tracer circulation times were based on previous 
studies using 18F- FDG in atherosclerosis7 16–18 and aimed 
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to produce optimal contrast between the aortic wall and 
the blood pool. In aneurysm subjects, with the patient in 
the same position, a CT aortogram from the diaphragm 
to the aortic bifurcation was performed using 75–100 mL 
of iodinated contrast (400 mgI/mL; Iomeron, Bracco, 
Milan, Italy), followed by 50 mL of 0.9% saline flush. 
The PET data were reconstructed using standard time 
of flight reconstruction algorithms. Corrections were 
applied for attenuation, dead time, scatter and random 
coincidences.
Image analysis
PET-CT
Anonymised PET- CT datasets were analysed using an 
OsiriX workstation (64 bit; OsiriX Imaging Software, 
Geneva, Switzerland).7 16–18 PET images were fused 
with corresponding CT datasets, and regions of interest 
(ROIs) drawn on serial axial slices. Within these 
regions, mean and maximum tracer activities were 
measured using standard uptake values (SUV; the decay 
corrected tissue concentration of the tracer divided by 
the injected dose per body weight) and corrected for 
blood pool activity in the superior vena cava to provide 
tissue- to- background ratios (TBRs).7 16–18 The average 
of the maximum TBR values within each slice was 
expressed as the mean TBRmax.
The aorta was divided into five segments for compar-
ison: ascending aorta, descending thoracic aorta, abdom-
inal non- aneurysmal aorta, aneurysm shoulder and 
aneurysm sac. The ascending aorta was defined as the 
segment of the aorta from the lower level of the right 
pulmonary artery up to the last slice where the aorta 
maintained its circular cross- sectional appearance. The 
descending thoracic aorta was defined as the region 
extending down from the circular slice below the arch 
of aorta to the slice where the diaphragm was first visible. 
The non- aneurysmal abdominal aorta was defined as the 
region between the descending aorta and the start of the 
aneurysm. The aortic aneurysm was defined as the region 
of abdominal aorta with all slices having a diameter of at 
least 3 cm. The aneurysm shoulder was defined as that 
segment of aorta bordering the first slice of aneurysmal 
aorta (two slices above and below the first 3 cm diameter 
slice). The aneurysm sac comprised the region between 
the aneurysm shoulder and the inferior aspect of the 
aneurysm.
Thrombus within the aneurysm was identified on 
the contrast CT aortogram using previously published 
Hounsfield unit definitions19 and sequential ROIs were 
drawn, avoiding overspill both from the lumen and aneu-
rysm wall.
CT calcium scoring
Calcium scoring was performed using a CT workstation 
(Vital Images, Minnetonka, Minnesota, USA). Total Agat-
ston scores were recorded for the entire aorta, using a 
threshold of 130 Hounsfield units for calcium on the 
non- contrast attenuation CT scan.20 In addition, arterial 
calcium scores, corrected for length of artery evaluated 
(in Agatston units per centimetre), were generated to 
allow comparison of aneurysmal segments in the aneu-
rysm group and equivalent length segments of non- 
aneurysmal aortae in control subjects.
Reproducibility studies
PET- CT data from 10 patients were selected at random 
to test the reproducibility of the 18F- FDG PET analyses. 
Two readers analysed the scans independently to provide 
a measure of the interobserver agreement for 18F- FDG 
uptake.
statistical analysis
Statistical analysis was performed using GraphPad 
Prism V.6 (GraphPad Software, USA) or SPSS V.19.0 
where appropriate. Continuous data were checked for 
normality using the D’Agostino- Pearson omnibus test. 
Parametric variables are expressed as means±SD and 
compared using Student’s t- tests or repeat measure one- 
way analysis of variance with Tukey’s multiple compar-
ison test when appropriate. Non- parametric data are 
presented as medians and IQRs and compared with the 
Mann- Whitney test, Wilcoxon matched- pairs signed rank 
or Friedman test as appropriate. Interobserver reproduc-
ibility was estimated using the Bland- Altman method and 
presented as mean bias ±2 SD, and intraclass correlation 
coefficients (ICC) with 95% CI. A two- sided p<0.05 was 
taken as statistically significant.
Results
Sixty- three patients with AAA and 19 age- and- sex- 
matched subjects with atherosclerosis and no aneurysm 
were recruited. In one patient, PET- CT acquisition was 
not completed according to protocol—that subject was 
therefore excluded from analysis as the imaging data 
were incomplete.
The aneurysm and atherosclerosis groups were well- 
matched for age, sex and other cardiovascular risk factors 
(table 1). The mean aneurysm diameter was 4.33±0.73 cm.
Inflammation results
Inflammation in aneurysm and atherosclerosis groups
Compared with age- and- sex- matched patients with ather-
osclerosis, patients with aneurysms had higher 18F- FDG 
uptake across their entire aorta (mean TBRmax 2.16±0.51 
vs 1.70±0.22, p=0.001). Greater inflammation was also 
noted in all individual aortic regions of aneurysm subjects 
compared with atherosclerotic controls (table 2).
Regionality of inflammation within aneurysm subjects
Among the aneurysm group, 18F- FDG accumula-
tion was greater within the aneurysm itself than in the 
non- aneurysmal segments of the aorta (mean TBRmax 
2.23±0.46 vs 2.12±0.46, p=0.024, figures 1 and 2 and 
table 3). Exploring further, 18F- FDG uptake was consist-
ently higher in both the sac and the shoulder regions of 
Open Heart
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Table 1 Baseline characteristics of all aneurysm and 
control subjects
Aneurysm 
group (n=63)
Controls 
(n=19)
Demographics
Male/female 56/7 17/2
Age, years 76.1±6.8 69.4±5.8
Aneurysm diameter, cm 4.33±0.73 –
Risk factors     
Current or ex- smoker 47 (75%) 14 (74%)
Hypertension 26 (42%) 7 (37%)
Type two diabetes mellitus 5 (8%) 1 (5%)
Prior MI 14 (22%) 11 (58%)
Prior stroke 8 (13%) 4 (21%)
Prior PVD 9 (14%) 4 (21%)
Medications     
Aspirin 48 (76%) 16 (84%)
Statin 53 (84%) 19 (100%)
Beta- blocker 21 (33%) 10 (53%)
ACEI or ARB 30 (48%) 13 (68%)
ACEI, ACE inhibitor; ARB, angiotensin- receptor blocker; MI, 
myocardial infarction; PVD, peripheral vascular disease.
Table 2 Comparison of inflammation and calcification in the aneurysm and matched control groups
Aneurysm subgroup
(n=19)
Matched controls
(n=19) P value
Ascending aorta
  Mean TBRmax 2.14±0.53 1.84±0.27 0.038
  Agatston score (median (IQR)) 18 (0–295) 0 (0–42) 0.246
  Agatston score/cm 6 (0–62) 0 (0–9) 0.218
Descending aorta
  Mean TBR
max 2.15±0.58 1.70±0.24 0.005
  Agatston score (median (IQR)) 267 (0–1230) 320 (170–842) 0.435
  Agatston score/cm 25 (0–72) 23 (16–67) 0.617
Abdominal aorta (incl. aneurysm)
  Mean TBR
max 2.23±0.45 1.68±0.21 <0.0001
  Agatston score (median (IQR)) 4483 (3105–9430) 2879 (941–7270) 0.112
  Agatston score/cm of abdominal aorta 245 (148–408) 166 (80–374) 0.307
  Agatston score/cm in aneurysm and control equivalent 442 (304–920) 166 (80–374) 0.004
Entire aorta
  Mean TBR
max 2.16±0.51 1.70±0.22 0.001
  Agatston score (median (IQR)) 5136 (3297–9360) 3735 (1425–8261) 0.180
  Agatston score/cm 144 (87–266) 109 (49–219) 0.230
Figure 1 Coronal and transaxial fused positron emission 
tomography and contrast CT images demonstrating 
focal 18F- FDG uptake within the aneurysmal wall (white 
arrowheads). Note also the calcified lateral aspect of the 
aneurysm.
the aneurysm than in any non- aneurysmal segment of the 
aorta (p=0.0004, table 4).
Association between inflammation and AAA size
There was no overall correlation between aneurysm size 
and 18F- FDG uptake within its wall (r=0.12, p=0.36). 
However, when divided into two groups by average aneu-
rysm diameter (4.33 cm), there was a non- significant trend 
toward more 18F- FDG uptake in smaller compared with 
larger aneurysms (mean TBRmax 2.36±0.45 vs 2.14±0.45, 
n=32 vs n=30, p=0.065).
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Figure 2 Coronal contrast CT, 18F- FDG positron emission 
tomography (PET) and fused images from a subject with a 
4.5 cm aneurysm demonstrating focal 18F- FDG uptake within 
the aneurysmal wall (golden colour on the PET images). Note 
also the presence of intraluminal thrombus and calcification.
Table 3 Inflammation and calcification in aortic aneurysm (n=63), comparing aneurysmal and non- aneurysmal aortic regions
Aneurysmal aorta (n=63) Non- aneurysmal aorta (n=63) P value
Mean TBRmax 2.23±0.46 2.12±0.46 0.024
Agatston score (median(IQR)) 4918 (2901–8008) 1017 (139–2226) <0.0001
The effect of aneurysm thrombus
Intraluminal thrombus was present in 43 of patients with 
aneurysm (69%). Subjects with no thrombus had higher 
18F- FDG uptake within their aneurysmal walls when 
compared with those with thrombus (mean TBRmax aneu-
rysm 2.43±0.45 vs 2.14±0.43, p=0.018). 18F- FDG uptake 
within the thrombus itself was consistently lower than 
in any region of the aortic wall in these subjects (mean 
TBRmax within thrombus 1.30±0.48 vs aneurysm wall 
2.23±0.46, p<0.0001).
Reproducibility of 18F-FdG measurements
The interobserver reproducibility of 18F- FDG measure-
ments was excellent across all aortic regions, including 
the aneurysm. Across the aorta as a whole, the Bland- 
Altman limits of agreement for mean TBRmax were 
0.04±0.07. Intraclass correlation coefficients were >0.90, 
with the shoulder and sac of the aneurysm having the 
lowest ICC values at 0.91 and 0.96, respectively.
Calcification results
Calcification in aneurysm and control subjects
In the aneurysm group, calcification was greater within 
the aneurysmal aortic wall than in the non- aneurysmal 
segments of aorta (4918 (2901–8008) vs 1017 (139–2226) 
Agatston units, p<0.0001). The extent of calcification was 
higher in the aneurysm sac than in all other aortic regions 
(p<0.0001, table 4). Consistent with these findings, aortic 
aneurysms were more calcified than the corresponding 
regions of abdominal aorta in atherosclerotic controls 
(442 Agatston units per cm (304–920) vs 166 (80–374), 
p=0.0042, table 2). Of note, no differences in calcification 
were noted between aneurysm subjects and controls in 
any other aortic region. No significant relationships were 
observed between aneurysm diameter and extent of calci-
fication (r=0.08, p=0.53). No differences were observed 
in the extent of wall calcification in those with or without 
intraluminal aneurysm thrombus (5310 (2748–9165) vs 
4903 (2952–7856), p=0.57).
Relationship between inflammation and calcification in AAA 
and atherosclerosis
There was no correlation between inflammation and 
calcification within aneurysms (r=−0.153, p=0.235). Simi-
larly, in the control group with atherosclerosis, there was 
no correlation between aortic inflammation and calci-
fication (total aorta: r=−0.19, p=0.45; abdominal aorta: 
r=−0.13, p=0.6).
dIsCussIOn
PET imaging to measure inflammation within aortic 
aneurysm was first reported in 2002.6 Our study is the 
first to measure both inflammation and calcification in 
patients with aneurysm and to compare the results with 
well- matched controls with atherosclerosis.
We found that patients with asymptomatic aortic 
aneurysms had excessive inflammation within the aneu-
rysmal segment of the aorta. Intriguingly, compared with 
matched controls with atherosclerosis, the entire aorta in 
those with an aneurysm was more highly inflamed. This 
suggests the presence of a global inflammatory aortop-
athy rather than a disease simply confined to the abdom-
inal aorta. We also found that intraluminal thrombus, a 
frequent feature of aneurysms, was metabolically inert, 
with little 18F- FDG uptake in most of our cases.
Calcification was also greatest in the aneurysmal part 
of the aorta in the aneurysm group and far more prev-
alent in patients with aneurysm than matched athero-
sclerotic subjects. Interestingly, in contrast to the global 
increase in aortic inflammation demonstrated in patients 
with aneurysm, calcification was not exhibited more 
than in controls in non- aneurysmal regions of their 
aortae. Further, there was also no correlation between 
the degree of calcification and inflammation in either 
cohort. This suggests that, while inflammation and calcifi-
cation are two important biological processes implicated 
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Table 4 Inflammation and calcification in aortic aneurysm (n=63),with values for each individual region of the aorta
Shoulder Sac Ascending Descending Abdominal P value
Mean TBRmax 2.26±0.49 2.25±0.46 2.12±0.41 2.15±0.38 2.13±0.38 0.0004
Agatston score (median(IQR)) 342
(109–7441)
4436
(2554–7441)
50
(0–674)
549
(118–1606)
1575
(717–3275)
<0.0001
Inflammation (mean TBRmax) and calcification (Agatston score) distribution in aneurysm subjects.
in aneurysm disease, they are distinct elements. Perhaps 
the global inflammation seen throughout the aorta 
represents an abnormal vasculature prone to aneurysmal 
dilatation, whereas calcification is more specific to the 
aneurysmal and biologically active portion of the vessel. 
Certainly, there is a suggestion that inflammation and 
calcification occur at different stages of the atheroscle-
rotic disease process.21
While there was no significant relationship observed 
between baseline aneurysm size and 18F- FDG uptake, 
consistent with a previous report22 smaller aneurysms 
appeared more 18F- FDG- avid than larger ones. This 
might be explained by a scenario where intense, early 
inflammation causes mechanical weakening of the aortic 
wall, allowing expansion to occur. Inflammation then 
reduces as the wall becomes more calcified. Indeed, 
there is good evidence that inflammation plays a crucial 
role in AAA development, and some have postulated that 
the anti- inflammatory actions of statins may be beneficial 
in reducing AAA growth.
What is the relationship between aortic aneurysm and 
atherosclerosis?
Aortic aneurysms frequently occur in patients with athero-
sclerosis. The two disease processes share several common 
risk factors, notably cigarette smoking.23 The underlying 
pathologies of the two conditions overlap to an extent, 
with inflammation and calcification being common to 
both. Nevertheless, there are important differences. 
Diabetes seems to protect against aneurysm formation 
and growth.23 While aneurysms are characterised by weak-
ening of the media of the aorta by chronic inflammation 
and degradation of the extracellular matrix,24 in athero-
sclerosis the main insult, at least initially, is to the intima 
of the artery. In atherosclerosis, a fibrous cap is typical 
over the necrotic core of the lesion, whereas in aneu-
rysm, there is very often a large adherent thrombus, vari-
ously described as protective against expansion in some 
studies25 and encouraging destabilisation in others.26 27 
The role of calcification is also debated in both condi-
tions.15 In atherosclerosis, macrocalcification is thought 
to be a healing response conferring plaque stability, but 
microcalcification appears to be associated with a risk of 
plaque rupture.28
Although calcification within aneurysms was a common 
feature, its role is less well understood than in atheroscle-
rosis. It is unclear whether aneurysm- associated macro-
calcification is a high- risk feature, suggestive of active, 
intense, necrotic inflammation, or whether it represents 
a burned- out pacified process following previous inflam-
mation. Data from the prospective SoFIA3 study high-
lighted the ability of 18F- fluoride PET to detect active 
aneurysmal microcalcification, with aneurysms with 
higher 18F- fluoride uptake having 2.5 times more rapid 
aneurysm expansion, and being nearly three times more 
likely to experience AAA repair or rupture, compared 
with patients with less aneurysmal microcalcification.29 
Whether the same holds true for macrocalcification 
remains unknown. Furthermore, the processes that 
govern calcification within the aneurysmal and the non- 
aneurysmal segments of aorta within aneurysm patients 
may well be distinct.
In terms of whether 18F- FDG uptake predicts future 
aneurysm behaviour, published work presents a mixed 
picture. There is evidence to suggest that 18F- FDG can 
discriminate between asymptomatic and symptomatic 
aneurysms, but its potential as a marker of aneurysm 
expansion and rupture has yet to be established.22 30–32 
There do appear to be positive correlations between the 
extent of 18F- FDG uptake and the degree of mechan-
ical wall stress within an aneurysm.33 Considerably more 
work is needed to determine whether data derived from 
advanced imaging, such as the extent of inflammation 
and calcification, can improve clinical decision- making 
and our understanding of this common condition.
COnClusIOn
Our study adds several important mechanistic insights 
into the pathobiology of AAAs. We observed that both 
aortic inflammation and calcification are greater in 
patients with aortic aneurysm than those with atheroscle-
rosis alone, that aortic inflammation typically extends 
beyond the aneurysmal sac to involve the entirety of the 
aorta and that greater thrombus burden is associated 
with less aneurysm inflammation. Future studies are 
needed to evaluate the prognostic value of measuring 
aortic inflammation and calcification to improve clinical 
decision- making in patients with asymptomatic AAA.
twitter Nikhil V Joshi @nvjoshi00 and James H F Rudd @jhfrudd
Contributors All authors contributed to the study.
Funding Funding was provided by the British Heart Foundation, The Evelyn Trust 
and the Academy of Medical Sciences. JHFR is supported by the NIHR Cambridge 
Biomedical Research Centre, HEFCE, the British Heart Foundation, the Wellcome 
Trust and the EPSRC Cambridge Mathematics In Healthcare Centre.
Competing interests None declared.
Patient consent for publication Not required.
7Joshi NV, et al. Open Heart 2020;7:e001141. doi:10.1136/openhrt-2019-001141
Aortic and vascular disease
ethics approval The study was performed in accordance with the protocol 
approved by the local research ethics committee and the Declaration of Helsinki.
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement Study data are available on reasonable request, 
subject to ethics board approval.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCId id
Nikhil V Joshi http:// orcid. org/ 0000- 0003- 4592- 1025
RefeRences
 1 Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune 
responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc 
Biol 2006;26:987–94.
 2 Ashton HA, Buxton MJ, Day NE, et al. The multicentre aneurysm 
screening study (mass) into the effect of abdominal aortic aneurysm 
screening on mortality in men: a randomised controlled trial. Lancet 
2002;360:1531–9.
 3 Filardo G, Powell JT, Martinez MA- M, et al. Surgery for small 
asymptomatic abdominal aortic aneurysms. Cochrane Database Syst 
Rev 2015:CD001835.
 4 Courtois A, Nusgens BV, Hustinx R, et al. 18F- Fdg uptake assessed 
by PET/CT in abdominal aortic aneurysms is associated with cellular 
and molecular alterations prefacing wall deterioration and rupture. J 
Nucl Med 2013;54:1740–7.
 5 Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning 
to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg 
2004;17:144–53.
 6 Sakalihasan N, Van Damme H, Gomez P, et al. Positron emission 
tomography (PET) evaluation of abdominal aortic aneurysm (AAA). 
Eur J Vasc Endovasc Surg 2002;23:431–6.
 7 McBride OMB, Joshi NV, Robson JMJ, et al. Positron emission 
tomography and magnetic resonance imaging of cellular 
inflammation in patients with abdominal aortic aneurysms. Eur J 
Vasc Endovasc Surg 2016;51:518–26.
 8 Rudd JHF, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose 
positron emission tomography imaging of atherosclerotic plaque 
inflammation is highly reproducible: implications for atherosclerosis 
therapy trials. J Am Coll Cardiol 2007;50:892–6.
 9 Rudd JHF, Warburton EA, Fryer TD, et al. Imaging atherosclerotic 
plaque inflammation with [18F]-fluorodeoxyglucose positron 
emission tomography. Circulation 2002;105:2708–11.
 10 Nordon IM, Hinchliffe RJ, Loftus IM, et al. Pathophysiology and 
epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 
2011;8:92–102.
 11 Makita S, Ohira A, Tachieda R, et al. Dilation and reduced 
distensibility of carotid artery in patients with abdominal aortic 
aneurysms. Am Heart J 2000;140:297–302.
 12 Diwan A, Sarkar R, Stanley JC, et al. Incidence of femoral and 
popliteal artery aneurysms in patients with abdominal aortic 
aneurysms. J Vasc Surg 2000;31:863–9.
 13 Vorp DA, Lee PC, Wang DH, et al. Association of intraluminal 
thrombus in abdominal aortic aneurysm with local hypoxia and wall 
weakening. J Vasc Surg 2001;34:291–9.
 14 Wang DH, Makaroun M, Webster MW, et al. Mechanical properties 
and microstructure of intraluminal thrombus from abdominal aortic 
aneurysm. J Biomech Eng 2001;123:536–9.
 15 Buijs RVC, Willems TP, Tio RA, et al. Calcification as a risk factor for 
rupture of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 
2013;46:542–8.
 16 Mäki- Petäjä KM, Elkhawad M, Cheriyan J, et al. Anti- Tumor necrosis 
factor-α therapy reduces aortic inflammation and stiffness in patients 
with rheumatoid arthritis. Circulation 2012;126:2473–80.
 17 Joshi NV, Toor I, Shah ASV, et al. Systemic atherosclerotic 
inflammation following acute myocardial infarction: myocardial 
infarction begets myocardial infarction. J Am Heart Assoc 
2015;4:e001956.
 18 Joshi NV, Vesey AT, Williams MC, et al. 18F- fluoride positron 
emission tomography for identification of ruptured and high- risk 
coronary atherosclerotic plaques: a prospective clinical trial. Lancet 
2014;383:705–13.
 19 Golledge J, Wolanski P, Parr A, et al. Measurement and  
determinants of infrarenal aortic thrombus volume. Eur Radiol 
2008;18:1987–94.
 20 Criqui MH, Denenberg JO, McClelland RL, et al. Abdominal aortic 
calcium, coronary artery calcium, and cardiovascular morbidity and 
mortality in the multi- ethnic study of atherosclerosis. Arterioscler 
Thromb Vasc Biol 2014;34:1574–9.
 21 Aikawa E, Nahrendorf M, Figueiredo J- L, et al. Osteogenesis 
associates with inflammation in early- stage atherosclerosis 
evaluated by molecular imaging in vivo. Circulation 
2007;116:2841–50.
 22 Kotze CW, Groves AM, Menezes LJ, et al. What is the relationship 
between ¹⁸F- FDG aortic aneurysm uptake on PET/CT and future 
growth rate? Eur J Nucl Med Mol Imaging 2011;38:1493–9.
 23 Brady AR, Thompson SG, Fowkes FGR, et al. Abdominal aortic 
aneurysm expansion: risk factors and time intervals for surveillance. 
Circulation 2004;110:16–21.
 24 Hellenthal FAMVI, Buurman WA, Wodzig WKWH, et al. Biomarkers of 
AAA progression. Part 1: extracellular matrix degeneration. Nat Rev 
Cardiol 2009;6:464–74.
 25 Thubrikar MJ, Robicsek F, Labrosse M, et al. Effect of thrombus on 
abdominal aortic aneurysm wall dilation and stress. J Cardiovasc 
Surg 2003;44:67–77.
 26 Hinnen J- W, Koning OHJ, Visser MJT, et al. Effect of intraluminal 
thrombus on pressure transmission in the abdominal aortic 
aneurysm. J Vasc Surg 2005;42:1176–82.
 27 Fontaine V, Jacob M- P, Houard X, et al. Involvement of the mural 
thrombus as a site of protease release and activation in human aortic 
aneurysms. Am J Pathol 2002;161:1701–10.
 28 New SEP, Goettsch C, Aikawa M, et al. Macrophage- Derived matrix 
vesicles: an alternative novel mechanism for microcalcification in 
atherosclerotic plaques. Circ Res 2013;113:72–7.
 29 Forsythe RO, Dweck MR, McBride OMB, et al. F- Sodium Fluoride 
Uptake in Abdominal Aortic Aneurysms: The SoFIA(3) Study. J Am 
Coll Cardiol 2018;71:513–23.
 30 Reeps C, Essler M, Pelisek J, et al. Increased 18F- 
fluorodeoxyglucose uptake in abdominal aortic aneurysms in 
positron emission/computed tomography is associated with 
inflammation, aortic wall instability, and acute symptoms. J Vasc 
Surg 2008;48:417–23.
 31 Truijers M, Kurvers HAJM, Bredie SJH, et al. In vivo imaging 
of abdominal aortic aneurysms: increased FDG uptake 
suggests inflammation in the aneurysm wall. J Endovasc Ther 
2008;15:462–7.
 32 Reeps C, Bundschuh RA, Pellisek J, et al. Quantitative assessment 
of glucose metabolism in the vessel wall of abdominal aortic 
aneurysms: correlation with histology and role of partial volume 
correction. Int J Cardiovasc Imaging 2013;29:505–12.
 33 Xu XY, Borghi A, Nchimi A, et al. High levels of 18F- FDG uptake in 
aortic aneurysm wall are associated with high wall stress. Eur J Vasc 
Endovasc Surg 2010;39:295–301.
